You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
26 May 2020
GlaxoSmithKline (GSK) Consumer Healthcare is working with Mammoth Biosciences to develop a COVID-19 test that can be used at home by consumers as well as in clinics by healthcare providers.
1 May 2020
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 46% at constant exchange rates in the first quarter of 2020, following consolidation of Pfizer’s Consumer Healthcare products and the COVID-19 pandemic.
8 April 2020
Perrigo is set to launch a store-brand version of GlaxoSmithKline (GSK) Consumer Healthcare’s topical pain reliever Voltaren Arthritis Pain in the US.
20 March 2020
The US Consumer Healthcare Products Association (CHPA) has created the new position of vice president for scientific affairs and dietary supplements, Europe’s Committee for Herbal Medicinal Products (HMPC) has elected a new chair, and GlaxoSmithKline (GSK) has a new non-executive director.
11 March 2020
Italy’s Angelini Pharma has acquired the global business rights – excluding North America – to GlaxoSmithKline’s (GSK’s) ThermaCare pain-management brand.
2 March 2020
GlaxoSmithKline (GSK) Consumer Healthcare is set to launch a combination pain reliever containing acetaminophen as well as ibuprofen in the US under its Advil brand.
24 February 2020
LG Household & Healthcare (LG H&H) is acquiring GlaxoSmithKline’s Physiogel skincare brand in Asia and North America.
19 February 2020
The US Food and Drug Administration (FDA) has switched GlaxoSmithKline’s (GSK’s) topical pain reliever Voltaren (diclofenac sodium topical gel 1%) from prescription-to-OTC status. GSK said the OTC version, called Voltaren Arthritis Pain, would be “available on US shelves in spring 2020”.
6 February 2020
GlaxoSmithKline (GSK) has announced a two-year programme that paves the way for the previously-announced separation of its Consumer Healthcare business into a standalone company.
9 January 2020
Strides Pharma Science has a new chief, The Carlyle Group has taken on Ian Read, and GlaxoSmithKline has a new member of its Corporate Executive Team.